P2X7 receptors in satellite glial cells mediate high functional expression of P2X3 receptors in immature dorsal root ganglion neurons by Chen, Yong et al.
RESEARCH Open Access
P2X7 receptors in satellite glial cells mediate high
functional expression of P2X3 receptors in
immature dorsal root ganglion neurons
Yong Chen, Guangwen Li and Li-Yen Mae Huang
*
Abstract
Background: The purinergic P2X3 receptor (P2X3R) expressed in the dorsal root ganglion (DRG) sensory neuron
and the P2X7 receptor (P2X7R) expressed in the surrounding satellite glial cell (SGC) are two major receptors
participating in neuron-SGC communication in adult DRGs. Activation of P2X7Rs was found to tonically reduce the
expression of P2X3Rs in DRGs, thus inhibiting the abnormal pain behaviors in adult rats. P2X receptors are also
actively involved in sensory signaling in developing rodents. However, very little is known about the
developmental change of P2X7Rs in DRGs and the interaction between P2X7Rs and P2X3Rs in those animals. We
therefore examined the expression of P2X3Rs and P2X7Rs in postnatal rats and determined if P2X7R-P2X3R control
exists in developing rats.
Findings: We immunostained DRGs of immature rats and found that P2X3Rs were expressed only in neurons and
P2X7Rs were expressed only in SGCs. Western blot analyses indicated that P2X3R expression decreased while
P2X7R expression increased with the age of rats. Electrophysiological studies showed that the number of DRG
neurons responding to the stimulation of the P2XR agonist, a,b-meATP, was higher and the amplitudes of a,b-
meATP-induced depolarizations were larger in immature DRG neurons. As a result, P2X3R-mediated flinching
responses were much more pronounced in immature rats than those found in adult rats. When we reduced P2X7R
expression with P2X7R-siRNA in postnatal and adult rats, P2X3R-mediated flinch responses were greatly enhanced
in both rat populations.
Conclusions: These results show that the P2X7R expression increases as rats age. In addition, P2X7Rs in SGCs exert
inhibitory control on the P2X3R expression and function in sensory neurons of immature rats, just as observed in
adult rats. Regulation of P2X7R expression is likely an effective way to control P2X3R activity and manage pain
relief in infants.
Keywords: Purinergic signaling, P2X3 receptors, P2X7 receptors, Dorsal root ganglion, P2X7R-P2X3R inhibitory con-
trol, Neuron-glia interactions, Nociception, Abnormal pain, Postnatal immature rats, Development
Background
The DRG neuron is the first (primary) neuron in the
somatosensory pathway relaying nociceptive (pain), itch
and other sensory information from the skin or internal
organs to the brain. The cell bodies (somata) of DRG
neurons are densely packed in a DRG. Each neuronal
soma is tightly wrapped by a layer of SGCs, which are
often coupled with one another through gap junctions
[1,2]. A neuronal soma with its surrounding SGCs is fre-
quently enclosed by a connective tissue sheath and
forms a distinct morphological unit [3]. There is no evi-
dence that classical synaptic contacts exist between neu-
ronal somata in DRGs [2]. We and others have shown
that neuronal somata communicate bidirectionally with
their surrounding SGCs in DRGs [4,5] and trigeminal
ganglia [6]. The communication modulates the activity
of somata thus affecting the afferent inputs into the
spinal cord [4].
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gated ion channels closely associated with the transmis-
sion of nociceptive signals in DRGs [5,7-10]. P2X3Rs are
expressed mainly in small- and medium-sized adult
DRG neurons [5,11] and P2X7Rs are expressed only in
SGCs [5,12,13]. We have shown that the P2X3R and
P2X7R are the two major purinergic receptors involved
in the bidirectional communication between neurons
and SGCs [4,5,14]. P2X3Rs have been shown to partici-
pate in peripheral pain signaling [15-18] and P2X7Rs
are involved in the maturation and release of cytokines
[19]. In addition, P2X7R knock-out mice fail to develop
hyperalgesia or allodynic pain under inflammation or
nerve injury conditions [20]. The evidence has led to the
suggestion that P2X7R activation is related to proinflam-
matory actions in the nociceptive system [21]. It was
therefore unexpected when we found that P2X7R activa-
tion in SGCs of adult DRGs tonically inhibits the
expression of P2X3Rs in neurons [5]. This inhibitory
P2X7R-P2X3R control attenuates the activity of P2X3Rs,
thus reducing signaling by P2X3R-expressing neurons,
most of which are nociceptors, under normal and
injured conditions [5,14].
In addition to signaling in adults, purinergic receptors
and ATP are found to actively participate in embryonic
development in mice and rats [22-25]. P2X3Rs can be
seen in day 9.5 mouse embryos (E9.5) [26] and 12.5 day
rat embryos [22]. From E14 to postnatal day 1 (P1),
P2X3Rs are present in nearly all DRG neurons. The
expression of P2X3Rs begins to decline after birth and
is expressed in ~73% of P7 and ~45% of P14 to adult
mouse DRG neurons. At the developmental stage (E14-
P7), most DRG neurons are small in size [23]. After P7,
some neurons start to mature into large cells. From P14
to adults, P2X3Rs are found mainly in small diameter
DRG neurons which account for ~50% of total adult
mouse DRG neurons [23]. P2X3Rs are found in ~ 40%
of adult rat DRG neurons [11]. Although P2X3R expres-
sion has been found to decrease with age, it is not
known if P2X7R expression increases with age and if




Neonatal (3-16 day old) and adult (~250 g) Sprague Daw-
ley rats were used in this study. For in vitro experiments,
rats were anesthetized with pentobarbital (50 mg/kg, i.p.)
and L4 and L5 DRGs were then removed. All experimen-
tal procedures were approved by the Institutional Animal
Care and Use Committee at University of Texas medical
Branch and were in accordance with the guidelines of the
National Institutes of Health and of the International
Association for the Study of Pain (IASP).
Western blots
For Western Blot experiments, DRGs were lysed in 100
μl of RIPA buffer (1% NP-40, 0.5% Na dexycholate, 0.1%
SDS, PMSF 10 μl/ml and aprotinin 30 μl/ml). The cell
lysates were centrifuged at 10,000× g for 12 min at 4°C.
The concentration of protein in homogenate was deter-
mined using a BCA reagent (Pierce). A 50 μgo ft o t a l
protein sample from each group was loaded onto a
SDS-PAGE, transferred to a PVDF membrane, incubated
with a blocking buffer (1 × TBS with 5% w/v fat free dry
milk) for 2 hrs and then with rabbit anti-P2X3 (1:1000;
Alomone), or anti-P2X7 (1:1000, Alomone) for another
2 hours at room temperature. The PVDF membrane
was then washed 5 times with TBST (1 × TBS and 1%
Tween 20), incubated with anti-rabbit peroxidase-conju-
gated secondary antibody (1:1000; Santa Cruz) for 1 hr
at room temperature and washed 5 times with TBST.
The immunoreactive proteins were detected by
enhanced chemiluminescence (ECL kit; Amersham Bios-
ciences) and visualized by exposing the PVDF mem-
brane onto an x-ray film. Loading controls were
determined by stripping the blots with a buffer contain-
ing 100 mM 2-mercaptoethanol, 62.5 mM Tris-HCl,
and 2% SDS for 20 min and re-probing with mouse
anti-Actin (1:1000, Chemicon) for 2 hr. After washing,
the membrane was incubated with anti-mouse peroxi-
dase-conjugated secondary antibody (1:1000, Chemica)
for 1 h. The intensity of protein bands was determined
using the NIH Image 1.63 software.
Immunohistochemistry
To immunostain DRG cells, rats were deeply anesthe-
tized with pentobarbital (80 mg/kg, i.p.) and fixed with
4% paraformaldehyde plus 0.2% picric acid. The L4 and
L5 DRGs were removed, postfixed for 1 hr and put in a
30% sucrose solution overnight. Tissue was then
embedded in an OCT compound and cut into 10 μm
transverse DRG sections on a cryostat and washed with
normal goat serum (10%) and Triton X (0.2%). Primary
antibodies used included rabbit anti-P2X7R (Alomone,
1:200) or guinea pig anti-P2X3R (Chemicon, 1:10,000).
Secondary antibodies included FITC or Texas Red anti-
rabbit, or anti-guinea pig IgG (Vector Lab, 1:200). To
compare the fluorescence intensity of labeled cells in
control and test groups, tissue samples from different
groups were processed simultaneously and analyzed
using an identical fluorescence intensity threshold. To
avoid the possibility of double-counting, labeled cells on
every fifth DRG section were analyzed.
Electrophysiology
To record the electrical activity of DRG neurons, one L4
or L5 DRG with an attached sciatic nerve was isolated
from a rat. The preparation was superfused with the
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(in mM) 115 NaCl, 5.6 KCl, 1 NaH2PO4, 2.0 CaCl2,1
MgCl2,1 1g l u c o s e ,a n d2 5N a H C O 3,a tr o o mt e m p e r a -
ture. Sharp electrodes filled with 3 M potassium acet-
ate with a resistance ranging from 50 MΩ to 90 MΩ
were used for recordings. DRG neurons were stimu-
lated either by square pulses (0.1-1 ms) applied to the
sciatic nerve through a suction electrode or by 40 ms
current steps applied to the soma through an intracel-
lular recording electrode. Only data obtained from
cells with a resting potential ≤ - 40 mV and overshoot-
ing spikes were accepted for analyses. In adult DRG,
cells were classified as Ab,A δ or C cells by axonal
conduction velocity (CV) with the criteria of CV > 8.5
m / sa sA b cells, CV = 1-8.5 m/s as Aδ cells, and CV <
1 m/s as C cells. In cases where CVs could not be
established, the action potential duration (APD), i.e.,
duration measured at the half peak AP amplitude, and
the existence of inflection on the falling phase of
action potential (AP) were used as the criteria to sepa-
rate cell groups [27]. Cells with an APD > 3.8 ms and
AP inflection were considered as C cells; cells with an
APD ≤ 3.8 ms and AP inflection were categorized as
Aδ cells; cells with an APD < 3.8 ms and no AP inflec-
tion were considered Ab cells. The same APD and AP
inflection criteria were used to categorize cell types of
DRGs in early postnatal ages, during which most of
the axons were unmyelinated [28]. Only C and Aδ
DRG neurons were included in our analyses. Chemi-
cals, e.g., a,b-meATP (100 μM) and TNP-ATP (1 μM)
were bath applied at a flow rate of ~ 4 ml/min. A
membrane potential change of ≥ 2 mV, which was lar-
ger than 2 times the standard deviation of the baseline
level, was set as a positive response, similar to the cri-
terion used by Stebbing et al. [29].
siRNAs
Small interfering RNA directed against P2X7 mRNA
(P2X7R-siRNA) or a non-targeting control siRNA (con-
siRNA) (20 μM, 10.5 μl) (Thermo Scientific) was used
in our experiments. The sense sequence of con-siRNA
was 5’-UAGCGACUAAACACAUCAA-3’.T h eP 2 X 7 R -
siRNA consisted of four pooled 21-necleotide duplexes.
The sequences were as follows: (1) Sense GAAACUGC-
CUCCCGUCUCAUU; Antisense 5’-P. UGAGACGGGA
GGCAGUUUCUU; (2) Sense GGAUCCAGAGCGUG
AAUUAUU; Antisense 5’-P UAAUUCACGCUCUGGA
UCCUU; (3) Sense CCAAGCCGACGUUAAAGUAUU;
Antisense 5’-P UACUUUAACGUCGGCUUGGUU; (4)
Sense GAUACGCCAAGUACUAUAAUU; Antisense 5’-
P UUAUAGUACUUGGCGUAUCUU. SiRNA-polyethy-
leneimine (PEI) complex (0.18 μl1 0 0m MP E Ip e rμg
RNA) was prepared according to the method described
by Tan et al. [30] before use.
Behavioral experiments
Nocifensive, i.e., flinching, behavioral studies were con-
ducted on P15-16 and adult rats, which were treated
with either con-siRNA or P2X7R-siRNA eight to nine
days before. The siRNA was applied intrathecally using
a modified direct transcutaneous intrathecal method
[31]. Rats were placed under individual plexiglass domes
and acclimated for 1 hr before experiments. Following
an injection of a,b-meATP (1 mM, 50 μl), rats were
immediately put back under the dome. The flinching
behavior was assessed by determining paw withdrawal
duration (PW duration), i.e., the total time that the
hindpaw was lifted in the air in a 1 min time bin
[32,33].
Data analyses
Data were expressed as means ± SE or as percentages.
Student’s t, Fisher Exact or Mann-Whitney tests were
used to access the significance of changes. Comparisons
between multiple means were done with one-way analy-
sis of variance (ANOVA) followed by the Holm-Sidak
post hoc test. A P< 0.05 was considered significant.
Results
A high percentage of DRG neurons express P2X3Rs in
immature rats
We first determined if P2X3Rs are expressed only in
DRG neurons and P2X7Rs are expressed only in SGCs
in immature rats as observed in adult cells [5]. DRG
neurons and SGCs were differentiated by their morpho-
logical characteristics. The somata of DRG neurons had
a rounded appearance with diameter ≥ 10 μm [34]. Each
soma had a prominent nucleus with relative clear
nucleoplasm and a low nucleus/cytoplasm ratio [35]. On
the other hand, SGCs were elongated (width ≤ 2 μm)
flattened cells that enveloped each neuronal soma
[35,36]. The SGC had a flattened nucleus which con-
tained dense chromatins and a high nucleus/cytoplasm
ratio. In P6 rats, P2X3R immunostain was found only in
DRG neurons, not in SGCs (Figure 1A). On the other
hand, P2X7Rs were found only in SGCs (Figure 1A). An
obvious difference in P2X3R distribution between imma-
ture and adult DRGs is that a high percentage of DRG
neurons expressed P2X3Rs in immature rats. In P6
DRGs, 74.83 ± 2.03% (n = 3) of DRG neurons expressed
P2X3Rs whereas only 43.45 ± 5.03% (n = 3) neurons
expressed P2X3Rs in adult DRGs neurons (Figure 1B).
The activity of P2X3Rs in DRG neurons decreases with rat
age
We then determined the function of P2X3Rs in DRG
neurons by measuring their responses to the P2XR ago-
nist, a,b-meATP. DRG neurons were categorized in C,
Aδ and Ab cell groups using the criteria described in
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studied only in C and Aδ cells. Sharp intracellular
microelectrodes were used to measure the depolariza-
tion induced by bath applied a,b-meATP (100 μM).
Under current clamp conditions, 11 out of 20 (55.0%)
recorded DRG neurons from P3-P14 rats responded to
a,b-meATP with ≥ 2 mV depolarization (Figure 2). The
average amplitude of a,b-meATP induced depolariza-
tions was 7.0 ± 0.8 mV (n = 11). In four immature neu-
rons, the effect of the P2X1R and P2X3R antagonist,
TNP-ATP, was also studied. TNP-ATP completely
blocked the a,b-meATP-induced depolarization (Figure
2A). Only 2 out of 13 (15.4%) neurons tested responded
to a,b-meATP in adult DRGs (Figure 2B). The average
amplitude of depolarizations induced by a,b-meATP in
adult DRG neurons (2.0 ± 0.0 mV, n = 2) was much
smaller than that obtained in immature DRGs (Figure
2C).
P2X7R-P2X3R inhibitory control exists in immature DRGs
In a previous study [5], we showed that reducing P2X7R
expression or blocking P2X7R activity in SGC cells
upregulates P2X3R expressions in adult DRG neurons.
This P2X7R-P2X3R inhibitory control is important in
maintaining proper functions of P2X3Rs. To determine
if such P2X7R-P2X3R control is also present in imma-
ture DRGs and if it contributes to the enhanced P2X3R
expression in immature rats, we first compared the
P2X3R and P2X7R protein expressions in DRGs isolated
from P6, P15 and adult rats. As rat aged, the P2X7R
expression increased (P6/Adult: 0.42 ± 0.05, n = 5; P15/
adult 0.64 ± 0.06; n = 3). At the same time, the P2X3R
expression was found to decrease (P6/adult: 1.71 ± 0.28;
P15/adult: 1.42 ± 0.11; n = 5) (Figure 3). Thus, P2X7R
and P2X3R expressions are negatively correlated, similar
to those observed in adult rats.
To determine the functional consequence of P2X7R-
P2X3R expression control in immature rats, nocifensive,
i.e., flinching, behavioral studies were conducted on
P15-16 and adult rats, which were treated with either
con-siRNA or P2X7R-siRNA. We applied P2X7R-siRNA
Figure 1 P2X3Rs are expressed in a higher percentage of DRG
neurons in immature rats.( A) Immunocytochemical staining of
P2X3Rs and P2X7Rs in DRGs of P6 and adult rats. P2X3R labels (red)
were found only in neurons; P2X7R labels (green) were found only
in SGCs. (Scale bars: P2X3R, P6 = 40 μm, Adult = 50 μm; P2X7R, P6
=2 5μm, Adult = 30 μm) (B) Percentage of DRG neurons
expressing P2X3Rs decreases significantly during postnatal
development (P6 rats: 74.83 ± 2.03%, n = 3; adult rats: 43.45 ±
5.03%, n = 3. Student t-test, *P < 0.05)
Figure 2 High P2X3R-mediated activity in DRG neurons of
immature rats.( A) a,b-meATP induced significant depolarizations
in DRG neurons of immature rats. In this example, a,b-meATP
evoked 8.6 mV depolarization in a P4 DRG neuron. The
depolarization was reversibly blocked by the P2X antagonist, TNP-
ATP (1 μM). (B) a,b-meATP induced a much reduced, i.e., 2 mV,
depolarization in an adult DRG neuron. (C) The percentage of DRG
neurons responded to a,b-meATP was high in immature rats and
greatly reduced in adult rats (P3-P14 rats: 55.0%, adult rats: 15.4%.
Fisher exact test, *P < 0.05). The amplitude of depolarizations
induced by a,b-meATP was reduced as rats matured (P3-P14 rats:
7.0 ± 0.8 mV, n = 11; adult rats: 2.0 ± 0 mV, n = 2. Mann-Whitney
test, *P < 0.05)
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sion. Eight to nine days later, the effect of P2X7R-
siRNA on P2X3R-mediated flinch behaviors induced by
a,b-meATP application to the rat left hindpaw was
determined. We first determined if P2X7R-siRNA is
effective in knocking down P2X7R expression and if
P2X3Rs are upregulated. Following P2X7R-siRNA treat-
ment, P2X7R expression was reduced (P2X7R-siRNA/
Con-siRNA = 0.52 ± 0.14, n = 4, Student t-test, P <
0.05), while the P2X3R expression in immature P2X7R-
siRNA rats was increased (P2X7R-siRNA/Con-siRNA =
1.32 ± 0.02, n = 3, P < 0.05) (Figure 4A). In presence of
con-siRNA, a,b-meATP-induced flinching responses
were much more pronounced in immature rats than
those found in adults. This result is consistent with the
observations that both P2X3R expression and function
are elevated in immature rats (Figures 1 and 2). Follow-
ing P2X7R-siRNA treatment, the a,b-meATP-induced
flinch behaviors in immature rats were significantly
enhanced, similar to that observed in adult rats (n = 4-
7 ,O n e - w a yA N O V A ,P<0 . 0 5 )( F i g u r e4 B ) .T h u s ,a
lower expression of P2X7Rs in immature DRGs resulted
in a higher expression and hence an enhanced function
of P2X3Rs. The observation suggests that P2X7R-P2X3R
inhibitory control plays an important role in regulating
the expression and function of P2X3Rs in immature
rats, as shown in adult rats (Figure 4B) [5].
Discussion
Our immunocytochemical study showed that the per-
centage of DRG neurons expressing P2X3Rs decreases
from 74.8% in P6 rats to 43.5% in adult rats (Figure 1),
a result similar to those obtained in mice [23]. During
postnatal development, P2X3R switches from being uni-
versally expressed in DRG neurons to limitedly
expressed in IB4-positive neurons [23]. In adult DRG
neurons, P2X3Rs are localized in small and medium-
sized DRG neurons that process nociceptive signals
[17,37,38]. To determine if the change in P2X3R expres-
sion corresponds to a change in P2X3R-mediated
responses, we studied the depolarizations evoked by the
P2X1R and P2X3R selective agonists, a,b-meATP, in
intact DRG neurons. Since P2X1 expression in DRGs is
low [38], the a,b-meATP-induced depolarization is
likely to be mediated mainly by P2X3R-containing
receptors in DRGs. We chose to determine P2X3R func-
tion in intact DRG neurons rather than in dissociated
DRG neurons because the cell dissociation procedure
appears to alter the percentage of cells responding to
the agonist [29]. We found that 55% of recorded DRG
n e u r o n so fP 3 - P 1 4r a t sr e s p o n d e dt oa,b-meATP
Figure 3 P2X3R expression decreases and P2X7R expression
increases with rat age. Western blot analyses of P2X3Rs and
P2X7Rs were conducted on the DRG protein samples isolated from
P6, P15 and adult rats. P2X3R and P2X7R expressions were
expressed in relative intensity with respect to those of adult rats,
which was set at 1.0. During postnatal development, the P2X7R
expression increased (P6/Adult: 0.42 ± 0.05; P15/adult 0.64 ± 0.06; n
= 3-5), while the P2X3R expression decreased (P6/adult: 1.71 ± 0.28;
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Figure 4 P2X7R-P2X3R inhibitory control exists in immature
rats.( A) P2X7R-siRNA treatment down-regulated P2X7R expression
while increased P2X3R expression in P15-16 rats. P2X3R and P2X7R
expressions in P2X7R-siRNA rats were expressed in relative intensity
with respect to those in Con-siRNA rats, which was set at 1.0. (B)
The a,b-meATP induced much more pronounced P2X3R-mediated
flinching responses in con-siRNA immature rats than in adult rats. In
both immature and adult rats, a,b-meATP evoked significantly larger
flinching responses in P2X7R-siRNA rats than in con-siRNA rats.
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tions in only 15.4% of adult DRG neurons, a percentage
similar to that obtained by Stebbing et al. [29]. Thus, an
increased number of DRG neurons expressed P2X3Rs
obtained from immunostain analyses is consistent with
an increased number of neurons responding to a,b-
meATP.
We also analyzed the a,b-meATP-induced depolariza-
tions in individual DRG neurons. The slow kinetics of
the a,b-meATP-induced depolarizations is likely a result
of bath application of the agonist [29]. Because of the
small percentage of adult DRG neurons responding to
a,b-meATP, the kinetic difference in the depolarizing
responses of immature and adult DRG neurons was not
studied. We found that the amplitudes of a,b-meATP-
induced depolarizations in individual adult DRG neu-
rons is ~3.5 fold smaller than those recorded in imma-
ture neurons (Figure 2).
We further studied the P2X3R expression using Wes-
tern analyses and P2X3R functions through behavioral
analyses. In immature rats, the P2X3R protein expres-
sion was high (Figure 3) and the a,b-meATP application
to the rat paw evoked much larger flinching behavioral
responses in immature rats (Figure 4B). An increase in
receptor expression in Western analyses and an increase
in behavioral responses could result from a larger num-
ber of cells expressing receptors and responding to a,b-
meATP respectively. They also can result from an
increase in the receptor expression and function in indi-
vidual neurons. Thus, an increase in the amplitude of a,
b-meATP evoked depolarizations in individual neurons
(Figure 2) is consistent with the results of Western and
behavioral analyses. Combining immunocytochemical,
electrophysiological and behavioral studies, we conclude
that P2X3R expression and P2X3R-mediated cellular
activity are high in immature DRG neurons and are
reduced as rats mature. The high level of P2X3R expres-
sion in the somata of immature DRG neurons is likely
to give rise to an enhanced transport of P2X3R receptor
to their nerve terminals and thus increased a,b-meATP-
induced behavioral responses. Nevertheless, the results
do not exclude the possibility that developmental
changes in the spinal circuitry and descending modula-
tion could also contribute to the observed changes in
the behavioral responses in immature rats.
We found that P2X3Rs are expressed only in DRG
neurons and P2X7Rs are expressed only in SGCs (Figure
1) in P6 rats, similar to those found in adult DRGs [5].
There are similarities and differences between the distri-
bution of P2X3Rs and P2X7Rs in DRGs and those in
the developing rat brain. Similarities include that
P2X3Rs are not found in glial cells [39] and P2X3Rs
mRNA expression decreases while P2X7R expression
increases and/or persists in the developing rat brain
[25]. Different from DRGs, in addition to expressing in
microglia cells, P2X7Rs are also expressed in brain neu-
rons, e.g., Purkinje cells in the cerebellum [40].
As animals mature, the P2X7R expression increases as
P2X3R expression decreases in DRGs (Figure 3). More
important, we showed that knocking down P2X7R
expression with P2X7R-siRNA significantly increases the
P2X3R-mediated flinch responses in P15-16 rats (Figure
4). Thus, P2X7Rs negatively control the expression and
function of P2X3Rs in immature rats just as those
observed in adult rats [5]. Since P2X7R expression is
low in P6-15 day rats (Figure 3), a reduced P2X7R-
P2X3R inhibitory control is likely a mechanism contri-
buting to the high expression and function of P2X3Rs in
DRGs of immature rats.
Many challenges exist in pain management in infants.
The expressions and functions of transmitters and
receptors undergo changes during development [41].
The descending control pathways from the brainstem to
the spinal cord in infants are not completely developed.
Sensory inputs are integrated, both spatially and tempo-
rally [41]. In addition, verbal communication with
infants is limited. Compared to adults, infants are more
sensitive to repeated noxious stimuli and chronic tissue
inflammation [42]. On the other hand, injury to periph-
eral nerves in infants gives rise to much less allodynia
and neuropathic pain than those observed in adults
[43,44]. Therefore, the information obtained from stu-
dies of pain treatment in adults is not directly applicable
to infants. We showed before that, in adult rats, total
P2X3R protein expression is upregulated in DRG neu-
rons after inflammation [45] and the membrane traffick-
ing of P2X3Rs increases following spared nerve injury
[32]. It is of interest to determine if purinergic receptors
respond to tissue and nerve injury in immature DRGs in
a similar manner as in adult DRGs. Our observations
that P2X3R and P2X7R expression are negatively corre-
lated (Figure 3) and P2X7R-P2X3R inhibitory control
also exists in developing rats (Figure 4) suggest that reg-
ulation of P2X7R expression in SGCs can be a useful
strategy for controlling P2X3R activity in sensory neu-
rons and relieving pain in infant patients.
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